Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2010-12-06 Major Shareholding Noti…
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Change in substantial holding 5 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a detailed notice regarding a change in substantial shareholding, specifically involving Dr. Michael Monsour and related entities. It references compliance with ASX Listing Rule 10.11 and includes a Form 604 under the Corporations Act 2001 Section 671B, which is a standard form used in Australia to notify changes in substantial holdings. The content focuses on share disposals, voting power changes, and relevant interests of the substantial holder and associates. There is no financial performance data, earnings information, or management discussion. The document is not an announcement of a report but a regulatory disclosure about shareholding changes. This fits the definition of a Major Shareholding Notification (MRQ).
2010-12-06 English
Change of Director`s Interest Notice 10 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed disclosures of changes in directors' relevant interests in securities, including direct and indirect holdings, dates of changes, and nature of transactions. It references ASX listing rule 3.19A.2 and section 205G of the Corporations Act, which govern director shareholding disclosures. The content is focused on reporting personal share transactions by company directors and related entities, with no financial performance data or company operational details. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is substantial and contains multiple such notices for different directors, confirming it is not a brief announcement but a full disclosure document. Therefore, the correct classification is DIRS (Director's Dealing).
2010-11-30 English
Appointment of Dr Terje Kalland To The Board 2 pages ?Kb
Board/Management Information Classification · 100% confidence The document is an announcement from CBio Limited regarding the appointment of Dr Terje Kalland as a Non-Executive Director to the company's board. It provides biographical details about Dr Kalland and some background about the company and its product pipeline. There is no financial data, no mention of a report or meeting, no voting results, no legal proceedings, no capital changes, and no earnings information. The content clearly relates to a change in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 3823 characters, which is consistent with a typical announcement rather than a full report or transcript.
2010-11-30 English
Initial Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including share options, and states the director's appointment date. The content focuses on disclosure of personal share transactions or holdings by a company director. There is no financial performance data, no report or announcement of financial results, no meeting materials, and no legal or governance information. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and specific to director interests, confirming it is not a broader regulatory or financial report. Therefore, the correct classification is DIRS with high confidence.
2010-11-30 English
Appendix 3Y Correction 10 pages ?Kb
Director's Dealing Classification · 95% confidence The document is a detailed Appendix 3Y filing, which is a Change of Director's Interest Notice under ASX Listing Rule 3.19A.2. It reports changes in shareholdings and interests of company directors, including off-market transfers and share disposals. The document includes specifics about directors, dates, number of shares before and after changes, and nature of transactions. It is not an annual report, earnings release, or any financial performance report. It is not a proxy statement or voting results announcement. It is not a regulatory certification or legal proceeding. The document is clearly a report of personal share transactions by company directors, which fits the definition of Director's Dealing (DIRS). The document length is substantial and contains detailed transaction data, not just an announcement or notice of a report. Therefore, the correct classification is DIRS with high confidence.
2010-11-30 English
Section 708A Notice 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act regarding the issuance of quoted share options by CBio Limited. It provides legal compliance statements related to the issuance of securities without disclosure under Part 6D.2 of the Corporations Act. The document is short (1117 characters) and is a formal regulatory announcement about a capital raising event but does not contain financial statements or detailed financial data. It is not a full report but a regulatory notice about a capital/financing activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2010-11-29 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.